Ebola-outbreak kills 5000 gorillas

December 08, 2006

The study also provides new hope for controlling the devastating impact of Ebola on wild gorilla and chimpanzee populations. Since reports of ape die-offs first circulated widely in 2003, sceptics have doubted how large these die-offs were and whether Ebola was even the cause. The new study, led by Magdalena Bermejo of the University of Barcelona, allays these doubts because it was conducted in a closely monitored gorilla population where genetic tests confirmed Ebola as the cause of death. Bermejo and colleagues from the Max Planck Institute for Evolutionary Anthropology and Uppsala University first showed that 93% (221 of 238) individually known gorillas at the Lossi Sanctuary in northwest Congo were killed by Ebola during outbreaks in 2002 and 2003. They then used transect surveys to show that 95% gorilla mortality rates extended over a much larger area of several thousand square kilometres. Chimpanzees were also heavily affected, with a mortality rate of 77%.

Lossi was just one in a series of large gorilla and chimpanzee die-offs caused by Ebola over the last twelve years. Accurate figures on exactly how many apes have died are not yet available. But given the large amount of prime habitat affected, these Ebola outbreaks may have killed as much as 25% of the world gorilla population. Particularly troubling has been the concentration of Ebola impact on large, remote protected areas that were designed to be the bulwarks of ape conservation efforts. Ebola has not totally made apes totally extinct from these areas but it has pushed once huge populations down to smaller sizes at which they are dramatically less resilient to illegal hunting and other looming threats.

Just as troubling are recent studies showing that the Ebola infection wave is spreading rapidly towards several of the remaining large protected areas in the region. Results from the new study suggest that protecting these remaining ape populations from Ebola may be much more feasible than previously appreciated. At Lossi, most gorillas appeared not to be infected directly from some reservoir host, as previously assumed. Rather, initial spillover from a reservoir host appeared to trigger an epidemic that spread from gorilla social group to gorilla social group. This opens the door to targeted vaccination strategies that, by breaking the chain of transmission, could be much more efficient than in the case of outbreaks driven entirely by reservoir spillover. The consistent spread rate of the Ebola infection wave also suggests that vaccination could be targeted just ahead of the advancing wave.

The current lack of a vaccination program is not due to a lack of vaccine options, as several different vaccines have now protected laboratory monkeys from Ebola and major vaccine labs are anxious to help. Rather, "Uncertainty about whether a large Ebola control effort was necessary or even possible has paralyzed large donors and major conservation organizations," said Peter Walsh, a co-author from Max Planck. "We are hoping that the starkness of our results will push some public or private donor to finally commit the two or three million dollars necessary to develop a safe and effective way of delivering Ebola vaccine to wild apes."

Walsh contends that Ebola vaccination is a cost effective method of ape conservation. "People in the conservation community are intimidated by the up-front costs of vaccination and would prefer to instead spend the money on anti-poaching. What they are not factoring in is the fact that one year of Ebola vaccination could save as many apes as decades of anti-poaching. We need to do both."

Walsh also points out that Ebola has the potential to quickly destroy years of ecotourism investment. For example, Bermejo's gorilla habituation program at Lossi was set up in the mid-1990's in collaboration with the European Union's Ecosystem Forestiere d'Afrique Centrale (ECOFAC) project to bring ecotourism revenue to local people. Ebola not only wiped out the habituated gorillas at Lossi, it also neutralized years of ecotourism investment in neighbouring Odzala National Park by devastating gorilla populations there.

"We are in a period where relatively modest investments in both Ebola control and anti-poaching would go a very long way towards insuring the future of our closest relatives," said Walsh. "Let's not blow it."
-end-


Max-Planck-Gesellschaft

Related Ebola Articles from Brightsurf:

Targeting the shell of the Ebola virus
As the world grapples with COVID-19, the Ebola virus is again raging.

Why doesn't Ebola cause disease in bats, as it does in people?
A new study by researchers from The University of Texas Medical Branch at Galveston uncovered new information on why the Ebola virus can live within bats without causing them harm, while the same virus wreaks deadly havoc to people.

Ebola transmission risks would be taken more seriously with ground-up interventions
A study led by the University of Kent's Durrell Institute of Conservation and Ecology (DICE) has found significant differences in disease risk perception and channels of information about Ebola virus disease (EVD) in rural areas and urban centres of Guinea, West Africa.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Ebola antibodies at work
Scientists in Israel and Germany show, on the molecular level, how an experimental vaccine offers long-term protection against the disease.

Half of Ebola outbreaks undetected
An estimated half of Ebola virus disease outbreaks have gone undetected since it was discovered in 1976, according to research published in PLOS Neglected Tropical Diseases.

Protecting those on the frontline from Ebola
Online training developed at the Medical University of South Carolina (MUSC) increased the knowledge of health care workers about effective prevention of Ebola up to 19 percent and reduced critical errors to 2.3 percent in a small MUSC cohort.

Another piece of Ebola virus puzzle identified
A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

How the human immune system protects against Ebola
'The current approach for treatment of filovirus infections with antibody cocktails tested in animal models utilizes the principle of targeting of non-overlapping epitopes.

How to slow down Ebola
The phylogenetic tree of the 2013-2016 Ebola epidemic doesn't just tell us how the Ebola virus was able to evolve: it also reveals which events and preventive measures accelerated or slowed down its spread.

Read More: Ebola News and Ebola Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.